Lv5
838 积分 2023-03-19 加入
Reactivating p53 mutants selectively in patients
19天前
已完结
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
26天前
已完结
Molecular subtyping of small-cell lung cancer in clinical practice: Primary tumor–lymph node concordance, intratumoral heterogeneity, and genomic context in a Chinese cohort
26天前
已完结
Reactivating p53 mutants selectively in patients
27天前
已完结
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy
1个月前
已完结
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
1个月前
已完结
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
1个月前
已完结
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors
2个月前
已完结
Vaccines for cancer prevention: exploring opportunities and navigating challenges
2个月前
已完结
皖公网安备34019202002308
